{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:59:13Z","timestamp":1761101953813},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T00:00:00Z","timestamp":1313625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10549-011-1733-6","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T15:54:47Z","timestamp":1313596487000},"page":"1057-1061","source":"Crossref","is-referenced-by-count":12,"title":["Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families"],"prefix":"10.1007","volume":"130","author":[{"name":"kConFab Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Harvey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. E.","family":"Birch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weideman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Goldgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,18]]},"reference":[{"issue":"5\u20136","key":"1733_CR1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00439-003-0908-6","volume":"112","author":"CL Scott","year":"2003","unstructured":"Scott CL, Jenkins MA, Southey MC, Davis TA, Leary JA, Easton DF, Phillips KA, Hopper JL (2003) Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. Hum Genet 112(5\u20136):542\u2013551","journal-title":"Hum Genet"},{"issue":"43","key":"1733_CR2","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/sj.onc.1209879","volume":"25","author":"AC Antoniou","year":"2006","unstructured":"Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898\u20135905","journal-title":"Oncogene"},{"issue":"2","key":"1733_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1200\/JCO.2007.11.0262","volume":"26","author":"SJ Dawson","year":"2008","unstructured":"Dawson SJ, Price MA, Jenkins MA, McKinley JM, Butow PN, McLachlan SA, Lindeman GJ, Weideman P, Friedlander ML, Hopper JL, Phillips KA (2008) Cancer risk management practices of noncarriers within BRCA1\/2 mutation\u2013positive families in the Kathleen Cuningham Foundation Consortium for research into familial breast cancer. J Clin Oncol 26(2):225\u2013232","journal-title":"J Clin Oncol"},{"issue":"1","key":"1733_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jmg.2006.043091","volume":"44","author":"A Smith","year":"2007","unstructured":"Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, Iddenden R, Woodward ER, Lalloo F, Maher ER, Evans DG (2007) Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 44(1):10\u201315","journal-title":"J Med Genet"},{"issue":"9","key":"1733_CR5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.gim.0000187155.63849.85","volume":"7","author":"TM Allweis","year":"2005","unstructured":"Allweis TM, Sagi M, Peretz T (2005) Sporadic breast cancer among relatives of BRCA mutation carriers. Genet Med 7(9):655\u2013656","journal-title":"Genet Med"},{"issue":"4","key":"1733_CR6","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1136\/jmg.2006.048462","volume":"44","author":"J Gronwald","year":"2007","unstructured":"Gronwald J, Cybulski C, Lubinski J, Narod SA (2007) Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling. J Med Genet 44(4):e76","journal-title":"J Med Genet"},{"issue":"8","key":"1733_CR7","first-page":"e86","volume":"44","author":"D Goldgar","year":"2007","unstructured":"Goldgar D, Venne V, Conner T, Buys S (2007) BRCA phenocopies or ascertainment bias? J Med Genet 44(8):e86 author reply e88","journal-title":"J Med Genet"},{"issue":"8","key":"1733_CR8","first-page":"e89","volume":"44","author":"E Rowan","year":"2007","unstructured":"Rowan E, Poll A, Narod SA (2007) A prospective study of breast cancer risk in relatives of BRCA1\/BRCA2 mutation carriers. J Med Genet 44(8):e89 author reply e88","journal-title":"J Med Genet"},{"issue":"2","key":"1733_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-009-0611-y","volume":"119","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Gaudet MM, Stopfer JE, Fleischaut MH, Powers J, Kauff N, Offit K, Nathanson KL, Robson M (2010) Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Res Treat 119(2):409\u2013414","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1733_CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-010-0923-y","volume":"125","author":"LA Korde","year":"2011","unstructured":"Korde LA, Mueller CM, Loud JT, Struewing JP, Nichols K, Greene MH, Mai PL (2011) No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families. Breast Cancer Res Treat 125(1):169\u2013173","journal-title":"Breast Cancer Res Treat"},{"key":"1733_CR11","unstructured":"Kathleen Cuningham Consortium for Research into Familial Breast Cancer: kConFab. Online resource. http:\/\/www.kconfab.org"},{"issue":"1","key":"1733_CR12","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1377","volume":"8","author":"GJ Mann","year":"2006","unstructured":"Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1733_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10689-004-6129-x","volume":"4","author":"KA Phillips","year":"2005","unstructured":"Phillips KA, Butow PN, Stewart AE, Chang JH, Weideman PC, Price MA, McLachlan SA, Lindeman GJ, McKay MJ, Friedlander ML, Hopper JL (2005) Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 4(2):105\u2013113","journal-title":"Fam Cancer"},{"key":"1733_CR14","unstructured":"AIHW (2010) In: Welfare AIoHa (ed) ACIM (Australian Cancer Incidence and Mortality) books. AIHW Australian Government, Canberra. http:\/\/www.aihw.gov.au\/acim-books\/"},{"issue":"6","key":"1733_CR15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0959-8049(00)00023-X","volume":"36","author":"PD Pharoah","year":"2000","unstructured":"Pharoah PD, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BA (2000) Familial predisposition to breast cancer in a British population: implications for prevention. Eur J Cancer 36(6):773\u2013779","journal-title":"Eur J Cancer"},{"issue":"3","key":"1733_CR16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1369-7625.2008.00494.x","volume":"11","author":"AD Bakos","year":"2008","unstructured":"Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH (2008) BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Health Expect 11(3):220\u2013231","journal-title":"Health Expect"},{"key":"1733_CR17","unstructured":"Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R; SEARCH collaborators, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Sch\u00fcrmann P, D\u00f6rk T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, kConFab, AOCS Management Group, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies multiple breast cancer susceptibility loci. Nature 447(7148):1087\u20131093"},{"issue":"12","key":"1733_CR18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S1470-2045(07)70348-0","volume":"8","author":"HA Katki","year":"2007","unstructured":"Katki HA, Gail MH, Greene MH (2007) Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families. Lancet Oncol 8(12):1042\u20131043","journal-title":"Lancet Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1733-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1733-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1733-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T10:58:50Z","timestamp":1592823530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1733-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1733"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1733-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2011,8,18]]}}}